Nanhua Bio Revenue vs. Return On Asset
| 000504 Stock | 10.30 0.12 1.15% |
Total Revenue | First Reported 2002-06-30 | Previous Quarter 30.4 M | Current Value 36.1 M | Quarterly Volatility 27.3 M |
For Nanhua Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nanhua Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nanhua Bio Medicine utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nanhua Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nanhua Bio Medicine over time as well as its relative position and ranking within its peers.
Nanhua |
Nanhua Bio Medicine Return On Asset vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Nanhua Bio's current stock value. Our valuation model uses many indicators to compare Nanhua Bio value to that of its competitors to determine the firm's financial worth. Nanhua Bio Medicine is the top company in revenue category among its peers. It is rated third in return on asset category among its peers . At present, Nanhua Bio's Total Revenue is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Nanhua Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nanhua Bio's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nanhua Revenue vs. Competition
Nanhua Bio Medicine is the top company in revenue category among its peers. Market size based on revenue of Communication Services industry is presently estimated at about 101.05 Billion. Nanhua Bio adds roughly 136.79 Million in revenue claiming only tiny portion of stocks in Communication Services industry.
Nanhua Return On Asset vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Nanhua Bio |
| = | 136.79 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Nanhua Bio |
| = | -0.0455 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Nanhua Return On Asset Comparison
Nanhua Bio is currently under evaluation in return on asset category among its peers.
Nanhua Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Nanhua Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nanhua Bio will eventually generate negative long term returns. The profitability progress is the general direction of Nanhua Bio's change in net profit over the period of time. It can combine multiple indicators of Nanhua Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Income Before Tax | -44.7 M | -42.5 M | |
| Net Loss | -11.4 M | -10.9 M | |
| Net Loss | -28.2 M | -26.8 M | |
| Income Tax Expense | 9.4 M | 9.9 M | |
| Operating Income | -9.1 M | -8.6 M | |
| Net Interest Income | -9.1 M | -9.6 M | |
| Interest Income | 2.3 M | 2.5 M | |
| Net Loss | -46.8 M | -44.4 M | |
| Change To Netincome | 25.5 M | 26.8 M |
Nanhua Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Nanhua Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nanhua Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nanhua Bio's important profitability drivers and their relationship over time.
Use Nanhua Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nanhua Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanhua Bio will appreciate offsetting losses from the drop in the long position's value.Nanhua Bio Pair Trading
Nanhua Bio Medicine Pair Trading Analysis
The ability to find closely correlated positions to Nanhua Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nanhua Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nanhua Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nanhua Bio Medicine to buy it.
The correlation of Nanhua Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nanhua Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nanhua Bio Medicine moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nanhua Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Nanhua Bio position
In addition to having Nanhua Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hybrid Mix Funds Thematic Idea Now
Hybrid Mix Funds
Funds or Etfs that are made of portfolios of stocks, bonds, or cash instruments with different maturity horizons and characteristics. The Hybrid Mix Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hybrid Mix Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Nanhua Stock
To fully project Nanhua Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Nanhua Bio Medicine at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Nanhua Bio's income statement, its balance sheet, and the statement of cash flows.